A new study recently published in Nature identifies a method for site-specific gene addition that may reduce adverse effects and lead to safe and more effective gene targeting. The study, conducted by researchers at Stanford and UCSF, was performed on mice with hemophilia B and demonstrated reduced bleeding in the mice and minimal side effects typically associated with other gene addition methods.
About the author
Julie Rogers is Research Development Associate in the Office of Research Funding & Development Services.
Other posts by this author:
- Reminder: RCR and human subjects training deadline, May 31
- OHSU Center for Women’s Health Circle of Giving awards two research grants
- Gerlinger Research Award applications due June 4
- Presidential bridge funding applications due June 15
- Pew Scholars Program for junior faculty; internal applications due June 5